関連する実験動画
Updated: Aug 19, 2026
15:52
Postproduction Processing of Electrospun Fibres for Tissue Engineering
Published on: August 9, 2012
血清ホモシステインはフェノフィブラートまたはベザフィブラートによる治療後に増加します
Lancet (London, England)
|July 27, 1999
まとめ
フェノフィブラートとベザフィブラートは,患者でホモシステインのレベルを有意に上昇させた. この増加は,ビタミン変化とは無関係ですが,腎臓機能と関連し,心血管の健康に影響を及ぼしている可能性があります.
科学分野:
- バイオケミストリー バイオケミストリー
- 薬理学 薬理学とは
- ネフロロジーは腎臓科
背景:
- ホモシステインの値上昇は,心血管疾患の危険因子です.
- 繊維酸は,一般的に処方される脂質低下剤です.
- 繊維酸の代謝効果,特にホモシステインに対する代謝効果については,さらなる解明が必要である.
研究 の 目的:
- フェノフィブラートとベザフィブラートがホモシステインレベルに与える影響を調査する.
- ホモシステインの変化の基礎となるビタミン状態と腎機能を含む潜在的なメカニズムを探求する.
主な方法:
- フェノフィブラートまたはベザフィブラートで治療された患者のホモシステインレベルを分析する観察研究.
- ビタミン濃度および腎機能パラメータの評価.
主要な成果:
- フェノフィブラート治療でホモシステインの44%の増加が観察されました.
- ベザフィブラート治療でホモシステインが17.5%増加した.
- ホモシステインの変化とビタミン濃度との間には相関関係が見つかりませんでしたが,腎機能との潜在的な関係が示唆されました.
結論:
- フェノフィブラートおよびベザフィブラート療法は,ホモシステインの有意な増加と関連しています.
- 観察された超ホモシスタイン血症は,ビタミン状態とは無関係である可能性が高い.
- 腎機能は,繊維酸誘発のホモシステイン上昇を媒介する上で重要な役割を果たす可能性があるため,さらなる調査が必要である.
関連する概念動画
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:24Serum Studies: Renal Function Tests
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.